Pfizer nears deal to provide U.S. with more vaccine doses

 

• Pfizer (NYSE:PFE) is close to an agreement with the Trump administration in which the company would bolster the supply of its coronavirus vaccine for the U.S. by at least tens of millions of doses next year in exchange for a government directive giving it better access to manufacturing supplies, New York Times reports.
• A deal, which could be announced as early as tomorrow, would help the U.S. at least partly offset a potential vaccine shortage that could leave as many as 110M adult Americans uncovered in H1 2021.
• The government is asking for 100M additional doses from Pfizer from April through June; the company has indicated it should be able to produce at least 70M doses and possibly more if it can gain more access to supplies and materials.
• Pfizer and partner BioNTech (NASDAQ:BNTX) as well as rival Moderna are the only two groups that have won U.S. emergency use authorization for their respective COVID-19 vaccine candidates.
• https://seekingalpha.com/news/3646861-pfizer-nears-deal-to-provide-u-s-vaccine-doses-nyt